ChatGPT did not cure a dog’s cancer
Why it matters: This case highlights the promise and peril of AI in medicine, underscoring the need for scientific rigor over hype.
- Paul Conyngham, Rosie's owner, used ChatGPT to brainstorm immunotherapy options and interpret genetic profiling results, leading to a personalized mRNA vaccine.
- University of New South Wales professor Pall Thordarson collaborated on the mRNA vaccine, noting it might be the first such treatment for a dog, but acknowledged Rosie was also receiving a checkpoint inhibitor.
- News outlets and social media, including figures like OpenAI's Greg Brockman and Elon Musk, amplified the story with exaggerated claims of a "cure" or AI-driven invention, losing the nuance of Conyngham's own cautious assessment.
- The scientific community, including Google DeepMind CEO Demis Hassabis, shared the story with less hype, recognizing the experimental nature and the combined treatment approach.
Despite viral claims of a ChatGPT-driven cancer cure for a dog named Rosie, the reality is far more nuanced: an entrepreneur used AI to explore treatment options, leading to a personalized mRNA vaccine alongside other immunotherapy, which improved Rosie's condition but did not eliminate all tumors.
